The CNS Summit has released the 2017
CNS Summit Innovation Index. It ranks life science companies based on publicly
available information, with regards to three facets of innovation: Trial
Optimization, Digital Advancement, and Innovative Partnerships. The Index
is powered by pharma innovation specialists IDEA Pharma.
Key findings show the rise of Astra
Zeneca, Boehringer Ingelheim, BMS, Celgene, and Bayer as emerging innovation
leaders. The goal of the CNS Summit Innovation
Index is to objectively assess investments made in innovation, encourage
leadership in innovation, and allow companies to benchmark their innovation
activities via an objective external source.
The CNS Summit, founded on the
principles of Collaboration, Innovation, and Technology, is a community working
collaboratively to shape the future of the life sciences. The CNS Summit
2017 is taking place November 16th—19th, 2017 in Boca Raton,
Florida.
Digital Intent provides the information about Pharmacy through Blog and website.
No comments:
Post a comment